Pharmacological treatment of severely depressed patients: a meta-analysis comparing efficacy of mirtazapine and amitriptyline

By Kasper S.   Zivkov M.   Roes K.C.B.   Pols A.G.  

European Neuropsychopharmacology, Vol. 7, Iss. 2, 1997-05 ,pp. : 115-124

Elsevier

Access to resources Recommend Favorite

Fluvoxamine treatment of alcoholic amnestic disorder

By Martin P.R.   Adinoff B.   Lane E.   Stapleton J.M.   Bone G.A.H.   Weingartner H.   Linnoila M.   Eckardt M.J.  

European Neuropsychopharmacology, Vol. 5, Iss. 1, 1995-03 ,pp. : 27-33

Elsevier

Access to resources Recommend Favorite

Cost Effectiveness of Fluvoxamine in the Treatment of Recurrent Depression in France

By Nuijten M.  

PharmacoEconomics, Vol. 14, Iss. 4, 1998-10 ,pp. : 433-445

Adis International

Access to resources Recommend Favorite

The treatment of dysthymia with sertraline: a double-blind placebo-controlled trial in dysthymic outpatients without major depression

By Guelfi J.D.   Wiseman R.L.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 289-290

Elsevier

Access to resources Recommend Favorite

Discontinuation Syndrome in Dysthymic Patients Treated with Selective Serotonin Reuptake Inhibitors: A Clinical Investigation

By Bogetto F.   Bellino S.   Revello R.B.   Patria L.  

CNS Drugs, Vol. 16, Iss. 4, 2002-01 ,pp. : 273-283

Adis International

Access to resources Recommend Favorite